Newsmax TV & Webwww.newsmax.comFREE - In Google Play
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
Dr. Mike Roizen
Dr. Mike Roizen is chief medical officer at the Cleveland Clinic Wellness Institute, an award-winning author, and has been the doctor to eight Nobel Prize winners and more than 100 Fortune 500 CEOs.

Dr. Mike Roizen

Tags: covid | inflammation | steroids | dr. roizen

Steroids Reduce the Risks From Long COVID

Michael Roizen, M.D. By Friday, 17 June 2022 11:32 AM EDT Current | Bio | Archive

The phrase "that's the long and short of it" — meaning something is summed up precisely — wandered into our lexicon via Shakespeare's "The Merry Wives of Windsor," in which Mistress Quickly uses the phrase turned around, "this is the short and long of it."

Well, that original version works very well today when we're talking about making short shrift of the dangers of long COVID-19.

Initial research published in the journal Frontiers of Medicine reveals that hospitalized patients who seemingly recover from severe COVID-19 run more than double the risk of dying within the next year compared to those with moderate symptoms who weren't hospitalized or those who never caught the illness.

And now a second study shows that patients hospitalized for COVID-19 with the most severe systemic inflammation have a 61% greater risk of dying of any cause within one year of leaving the hospital than patients with the lowest markers for inflammation. 

The short of it, however, is that the research also shows some of long COVID-19's risks can be countered. How? By prescribing anti-inflammatory steroids when patients leave the hospital. That appears to reduce their risk of death in the following months by up to 51%.

This is an important step in understanding that COVID-19 often acts like a chronic disease. The knowledge may lead to ways to reduce the risk for later cardiovascular problems and brain dysfunction.

If you have a serious COVID-19 infection, ask your doctor if you should receive a steroid — or even an aspirin — routinely for the next few weeks. 

© King Features Syndicate

Research shows that some of long COVID's risks can be countered by prescribing anti-inflammatory steroids when patients leave the hospital.
covid, inflammation, steroids, dr. roizen
Friday, 17 June 2022 11:32 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
Find Your Condition
Get Newsmax Text Alerts

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved
© Newsmax Media, Inc.
All Rights Reserved